James F. Jordan, MBA, CHT

James F. (Jim) Jordan is an active industry expert in healthcare and the life sciences. With a life-long passion for learning, Jim’s business accomplishments, combined with his academic achievements, enable him to apply his broad field of knowledge and experience to further understanding and foster success. A dynamic communicator, Jim is an active author, speaker, and consultant.

Jim is an accomplished Fortune 20-level executive with companies such as Boston Scientific, Johnson & Johnson, and McKesson. He also has extensive experience with life science start-up ventures, and is active on multiple Boards of Directors. Jim, in his role as an innovation leader, has also been ask to serve on several advisory boards. Jim is a certified hypnotherapist (CHT) and has developed the NeuroAcceleration™ System, a change management tool, to help groups in times of transition. Jim has served as a Distinguished Service Professor of Healthcare & Biotechnology Management and Senior Director of Healthcare and Biotechnology Programs at Carnegie Mellon University’s Heinz College, as well as President and CEO of The Pittsburgh Life Sciences Greenhouse, a public-private economic development organization and venture fund owned by Carnegie Mellon University and the University of Pittsburgh. Through the Pittsburgh Life Sciences Greenhouse, he has applied his 25 years of experience in industry, consulting, and academia to work with over 400 life science start-up companies, with direct investment in 75 of them. Jim is also the Managing Director of a venture capital fund. 

Prior to joining the PLSG, Mr. Jordan served as Senior Vice President of a $3.0 billion division of McKesson Corporation, a leading distributor of healthcare systems, medical supplies, and pharmaceutical products, and as a Vice President for Marketing at Johnson & Johnson, one of the world’s largest consumer products and healthcare companies.  He has held a range of management positions in sales and marketing, operations, supply chain management, information technology, finance, and quality assurance with several Fortune 500 medical device companies, including C.R. Bard, Inc. and Boston Scientific, Inc.  Mr. Jordan has leveraged this experience in several start-up ventures and is active on several Boards of Directors, including the Pittsburgh Venture Capital Association.

Mr. Jordan’s experience, which also includes consulting engagements with numerous companies such as Medtronic, Frost & Sullivan, Circuit City, Philip Morris, Northrop Grumman, Schwartz Pharmaceutical, and Otsuka Pharmaceutical, is documented in his book, titled Innovation, Commercialization, and Start-ups in Life Sciencespublished by CRC Press ©2015 by Taylor & Francis Group Ltd., which is available on Amazon.  This textbook details the necessary data, partnerships, and skills to be acquired and the constituencies that must be satisfied along the way to a successful exit.

Mr. Jordan previously served as an Adjunct Associate Professor at the Robins School of Business at University of Richmond, where he taught Introduction to Managing Projects, Advanced Project Management, PMP Certification Test Preparation, and Project Risk Management.  Mr. Jordan joined Carnegie Mellon University’s Heinz College of Information Systems and Public Policy in 2005 and serves as Distinguished Service Professor of Health Care and Biotechnology Programs, and also as Strategic Board Chairman-Center for Healthcare Innovation.  He holds a Bachelor of Science Degree in Business Administration from Merrimack College and a Master of Business Administration degree from Boston University.

Most recently, Mr. Jordan co-authored The Intellectual Property Pyramid Assessment: A Novel Method for Creating a Sustainable Competitive Advantage, a new workbook and method designed to help individuals, companies, investors, and patent attorneys develop comprehensive IP strategies, assess the strength of existing IP portfolios, and create a significant competitive advantage.  The IP workbook is available on Amazon.

James F. Jordan by the Numbers:

Years of Experience

Companies Supported

Direct Investments

Connect with Jim